Rise in COPCOV numbers continues; study to end recruitment 30 Nov
A global study examining the impact of chloroquine / hydroxychloroquine in preventing COVID-19, COPCOV has recruited 3,491 participants as of 3 November from sites in Benin, Côte d’Ivoire, Indonesia, Kenya, Mali, Nepal, Pakistan, Zambia, and closed sites in Thailand, Niger and the UK. COPCOV will recruit new participants until 30 Nov 2021, with preliminary study results expected Q1 2022.
Triple artemisinin-based combination therapies for malaria: proceed with caution - Authors' reply.
van der Pluijm RW. et al, (2021), Lancet (London, England), 396, 1976 - 1977
Boosting heritability: estimating the genetic component of phenotypic variation with multiple sample splitting
Mai TT. et al, (2021), BMC Bioinformatics, 22
Evolutionary histories and antimicrobial resistance in Shigella flexneri and Shigella sonnei in Southeast Asia
Chung The H. et al, (2021), Communications Biology, 4